Autoimmune Skin Conditions in Children

Autoimmune skin conditions occur when the immune system mistakenly targets parts of the body, leading to inflammation or changes affecting the skin, hair, or nails.

These conditions:

• Are not infectious

• Cannot be passed between children

• Vary widely in how they present and in severity

Some remain limited to the skin, while others may be associated with autoimmune activity elsewhere in the body.

Examples of autoimmune skin conditions that may be seen in children include:

• Alopecia areata

• Vitiligo

• Autoimmune blistering conditions (rare in childhood)

• Connective tissue–related skin conditions affecting the skin (rare)

Each condition behaves differently and requires individual assessment.

Alopecia areata is an autoimmune condition that causes sudden, patchy hair loss, most commonly on the scalp, but sometimes affecting eyebrows, eyelashes, or other hair-bearing areas.

It occurs when the immune system temporarily targets hair follicles. The follicles are not permanently damaged, which means hair regrowth is often possible.

Severity varies widely.

Alopecia areata may involve:

• A small number of patches with spontaneous regrowth

• More extensive scalp involvement

• Rarely, more widespread hair loss

Many children experience partial or complete regrowth, although the course can be unpredictable.

No. No treatment is a valid option, particularly when:

• Hair loss is limited

• There is early or spontaneous regrowth

• The child is not distressed

In some cases, the immune activity settles on its own and hair regrows without intervention.

Treatment is individualised and depends on the child’s age, extent of hair loss, rate of progression, and impact on wellbeing.

Options may include:

• Topical treatments applied to affected areas

• Targeted treatments delivered directly to involved skin in selected cases

• Systemic therapies for more extensive or progressive disease

The benefits, risks, and goals of treatment are discussed carefully with families, and treatment plans may change over time.

Yes. Some children may develop nail changes, such as:

• Pitting

• Ridging

• Thinning or roughness of the nails

Nail involvement occurs in a subset of children and can be associated with more extensive or persistent disease, although this is not always the case. These changes can support the diagnosis and help guide assessment and follow-up.

Children with one autoimmune condition may have a higher risk of another, although many do not develop additional conditions.

Assessment includes:

• A thorough personal and family history of autoimmune disease

• Review for symptoms suggesting other autoimmune conditions

• Deciding whether investigations or monitoring are appropriate

This approach helps identify issues early while avoiding unnecessary testing.

Vitiligo is an autoimmune condition that causes loss of skin pigment, resulting in white or lighter patches of skin.

Vitiligo is:

• Not infectious

• Not harmful

• Not caused by anything a parent or child has done

Vitiligo can present in different patterns, including:

• Acrofacial vitiligo (hands, feet, face)

• Generalised vitiligo (more widespread involvement)

• Segmental vitiligo (affecting one side or segment of the body)

The pattern of vitiligo can help guide prognosis and management decisions.

No. Vitiligo can be:

• Stable for long periods

• Slowly progressive

• Variable over time

Some children have limited involvement that remains unchanged, while others may develop additional patches.

Treatment is individualised and depends on:

• The type and extent of vitiligo

• Location of affected areas

• Age of the child

• Impact on wellbeing

Options may include:

• Topical treatments to encourage repigmentation

• Targeted light-based therapies for limited areas in selected cases

• Phototherapy or systemic treatments for more active or widespread disease

• No active treatment, with monitoring only

• Camouflage techniques to reduce visibility if desired

Choosing not to treat is a valid option for many children and families.

Vitiligo itself does not cause physical illness. However, children with vitiligo may have a higher risk of other autoimmune conditions, which is why careful assessment and follow-up are important.

Evaluation focuses on:

• A detailed family history

• Assessment for symptoms suggesting associated conditions

• Targeted investigations only when appropriate

Yes. Vitiligo can affect confidence and self-esteem, particularly when patches are visible.

Management includes:

• Clear explanation and reassurance

• Discussing treatment and camouflage options

• Supporting the child and family emotionally

Stress does not cause autoimmune skin conditions, but it may influence disease activity in some children.

Physical or emotional stress can sometimes coincide with flares or changes in disease activity. Supporting overall wellbeing and emotional health is an important part of care.

Routine screening of siblings is not usually required.

However, a family history of autoimmune disease is relevant, and review is recommended if another child develops skin, hair, or nail changes suggestive of an autoimmune condition.

There is no proven way to prevent progression of autoimmune skin conditions.

Management focuses on:

• Early recognition of changes

• Individualised treatment when appropriate

• Monitoring over time

• Supporting skin health and overall wellbeing

Some conditions remain stable for long periods, while others may change unpredictably.

Specialist review is recommended if:

• Skin or hair changes are persistent or progressive

• There is patchy hair loss or loss of pigment

• Symptoms are affecting confidence or quality of life

• There is a family history of autoimmune disease

• There are concerns about associated conditions

Early review helps guide diagnosis, monitoring, and long-term planning.

At Ready Dermatology, North Shore Health Hub, St Leonards, our dermatologist provides assessment and management of autoimmune skin conditions in children. Care focuses on accurate diagnosis, appropriate investigation, safe and effective treatment, and long-term support for children and their families.